✦ LIBER ✦

Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumours

✍ Scribed by M.J.A. de Jonge; H. Dumez; J. Verweij; S. Yarkoni; D. Snyder; D. Lacombe; S. Marréaud; T. Yamaguchi; C.J.A. Punt; A. van Oosterom

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cabazitaxel in patients with advanced so

✍ V. Diéras; A. Lortholary; V. Laurence; R. Delva; V. Girre; A. Livartowski; S. As 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 396 KB

Phase I clinical, pharmacokinetic and ph

✍ Razak, A R A; Hotte, S J; Siu, L L; Chen, E X; Hirte, H W; Powers, J; Walsh, W; 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 308 KB

421 POSTER Phase I dose escalation and p

✍ T. Mukohara; S. Nagai; Y. Nambu; K. Yoshizawa; H. Minami 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Phase I and pharmacokinetic study of com

✍ Stefan R. Vink; Jan H.M. Schellens; Jos H. Beijnen; Herbert Sindermann; Jürgen E 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Novel paclitaxel formulations for oral a

✍ S. A. Veltkamp; H. Rosing; A. D. R. Huitema; M. R. Fetell; A. Nol; J. H. Beijnen 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 367 KB

Phase I safety and pharmacokinetic study

✍ M.J.A. de Jonge; H. Dumez; J.J.E.M. Kitzen; B. Beuselinck; J. Verweij; R. Courtn 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 305 KB